Oxytroflavoside G

Catalog No. :
ACPSJQ307
CAS No. :
1391144-89-0
Molecular Formula :
C34H42O19
Molecular Weight :
754.69

IUPAC Name:3-(((2S,3R,4S,5R,6R)-4,5-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

Oxytroflavoside G structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameOxytroflavoside G
IUPAC Name3-(((2S,3R,4S,5R,6R)-4,5-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one
Molecular FormulaC34H42O19
Molecular Weight754.69
SMILESO=C1C(O[C@H]2[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)O2)=C(C5=CC=C(O)C=C5)OC6=C1C(O)=CC(OC)=C6
InChI KeyJGDLCWFCXJLERP-DMXBUQNHSA-N
Synonym4H-1-Benzopyran-4-one, 3-[(O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[6-deoxy-α-L-mannopyranosyl-(1→6)]-β-D-galactopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-;Oxytroflavoside G
CAS No.1391144-89-0

Synthetic Route by SureRoute

1. ACPSJQ307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPSJQ307 route product structure diagram
    ACPSJQ3071391144-89-0
Inquiry

2. ACPSJQ307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPSJQ307 route product structure diagram
    ACPSJQ3071391144-89-0
Inquiry

Comments (0)